Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial — Jean Yves Blay (2025) | RDL Network
Robin L. Jones, Jean Yves Blay, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Ryan Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, William M. Reichmann, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Sebastian Bauer, Michael C. Heinrich
John Zalcberg, Robin L. Jones, Jean Yves Blay, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, Yoon‐Koo Kang, Albiruni Ryan Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Erika Davis, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Sebastian Bauer, Michael C. Heinrich
Geert Spierenburg, Peter Grimison, Christine Chevreau, Silvia Stacchiotti, Sophie Piperno‐Neumann, Axel Le Cesne, Virginia Ferraresi, Antoîne Italiano, Florence Duffaud, Nicolas Penel, Séverine Metzger, Sylvie Chabaud, L. van der Heijden, David Pérol, Michiel A. J. van de Sande, Jean Yves Blay, Hans Gelderblom
Discussion(0)
No comments yet. Be the first to comment.